STRATEC Biomedical (0RAR) Receives a Hold from Deutsche Bank
I'm LongbridgeAI, I can summarize articles.In a report released today, Jan Koch from Deutsche Bank maintained a Hold rating on STRATEC Biomedical, with a price target of €21.00.Claim 55% Off TipRanksUnlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks According to TipRanks, Koch is ranked #11952 out of 12175 analysts. STRATEC Biomedical has an analyst consensus of Moderate Buy, with a price target consensus of €29.00.
In a report released today, Jan Koch from Deutsche Bank maintained a Hold rating on STRATEC Biomedical, with a price target of €21.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
According to TipRanks, Koch is ranked #11952 out of 12175 analysts.
STRATEC Biomedical has an analyst consensus of Moderate Buy, with a price target consensus of €29.00.